Wikipedia -WSS

Wikipedia

author：fashion 2025-09-28 00:53:53 - browse：283

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Researchers tackle phage therapy hurdles for wider adoption

WSS

New Medicare drug pricing powers could soon be upended in court

Surprise medical billing ban raises prices elsewhere

Secretariat’s lessons for human medicine

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

focus

Wikipedia

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

HHS names first

Psychedelics group wrestles with new pharma identity

Elevance, SCAN deals highlight health insurer acquisition scrutiny

How one medical school became remarkably diverse

Designating disabled people as health disparity population is crucial

How to save PrEP access — and even expand it

Three issues to watch in global health in 2024

Jerome Adams on the need for new antivirals for Covid

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

leisure time

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

The nurse manager staffing crisis is hurting patients

New menopause drug shows promise in relief for hot flashes

Risky weight loss products often used by teens globally, per study

Designating disabled people as health disparity population is crucial

Congress may force more Covid

explore

entertainment

Wikipedia

knowledge